Centric Health Corp. (TSE:CRX – Free Report) – Stock analysts at Desjardins dropped their FY2025 EPS estimates for shares of Centric Health in a research note issued on Sunday, November 10th. Desjardins analyst G. Ho now forecasts that the company will post earnings per share of $0.10 for the year, down from their prior estimate of $0.12.
CRX has been the subject of several other reports. Stifel Canada cut Centric Health from a “strong-buy” rating to a “hold” rating in a research report on Monday, August 12th. Ventum Cap Mkts upgraded shares of Centric Health to a “strong-buy” rating in a research report on Thursday, August 8th.
Centric Health Price Performance
See Also
- Five stocks we like better than Centric Health
- What Do S&P 500 Stocks Tell Investors About the Market?
- Home Depot Stock: Targeting 12% in 2024 and 25% More in 2025
- Dividend Capture Strategy: What You Need to Know
- Is Tesla’s Valuation a Bubble or Backed by Real Growth?
- How to Invest in Blue Chip Stocks
- Trucking Stocks Led the Pack Last Week: Can They Keep Rolling?
Receive News & Ratings for Centric Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Centric Health and related companies with MarketBeat.com's FREE daily email newsletter.
